C1orf57 Activators
Items 11 to 20 of 23 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of the JNK pathway, SP600125 would reduce C1orf57 activity if C1orf57 is part of cellular responses mediated by JNK signaling. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore that elevates intracellular calcium levels. It can activate C1orf57 via calcium-dependent signaling pathways, potentially influencing its activity and cellular functions. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Another PI3K inhibitor, Wortmannin would lead to a decrease in PI3K/AKT pathway signaling, potentially diminishing C1orf57 activity if it is part of this pathway. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR activates AMP-activated protein kinase (AMPK), which can indirectly impact C1orf57 by modulating cellular energy metabolism and signaling pathways associated with its function. | ||||||
Dimethyl Sulfoxide (DMSO) | 67-68-5 | sc-202581 sc-202581A sc-202581B | 100 ml 500 ml 4 L | $31.00 $117.00 $918.00 | 136 | |
DMSO can induce C1orf57 expression by acting as a solvent for certain C1orf57-activating compounds. It may facilitate the delivery of other activators to enhance C1orf57 activity. | ||||||
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $94.00 $208.00 | 19 | |
An inhibitor of the Hedgehog signaling pathway, Cyclopamine could decrease C1orf57 activity if C1orf57 is involved in this pathway. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine is a DNA demethylating agent that can indirectly activate C1orf57 by reducing DNA methylation at its promoter region. This epigenetic modification may increase C1orf57 expression. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
A MEK inhibitor that prevents the activation of MAPK/ERK, U0126 could lead to diminished C1orf57 activity if C1orf57 operates within this signaling cascade. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, a histone deacetylase inhibitor, can promote C1orf57 expression by increasing histone acetylation at the C1orf57 gene locus. It indirectly influences C1orf57 activity through epigenetic modifications. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor, Bortezomib could decrease C1orf57 activity indirectly by increasing the level of proteins that are degraded by the proteasome, potentially affecting pathways that C1orf57 is involved in. | ||||||